We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
-15.16%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$1.4B
AUM Growth
-$1.05B
Cap. Flow
-$737M
Cap. Flow %
-52.65%
Top 10 Hldgs %
29.68%
Holding
181
New
76
Increased
18
Reduced
42
Closed
45

Sector Composition

Rank Sector Weight
1 Healthcare 45.77%
2 Technology 31.94%
3 Communication Services 11.78%
4 Consumer Discretionary 2.11%
5 Industrials 1.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNPS icon
76
Synopsys
SNPS
$76.7B
$5.84M 0.42%
+45,335
New +$6.45M
SWTX
77
DELISTED
SpringWorks Therapeutics
SWTX
$5.69M 0.41%
+210,893
New +$6.88M
WBA
78
DELISTED
Walgreens Boots Alliance
WBA
$5.69M 0.41%
+124,448
New +$6.32M
GLUU
79
DELISTED
Glu Mobile Inc.
GLUU
$5.55M 0.4%
882,935
-1,354,758
-61% -$8.73M
MNTA
80
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$5.41M 0.39%
198,867
-280,632
-59% -$7.81M
PINS icon
81
Pinterest
PINS
$13.1B
$5.16M 0.37%
+334,310
New +$6.51M
CIEN icon
82
Ciena
CIEN
$57.9B
$5.11M 0.37%
+128,405
New +$5.27M
DHR icon
83
Danaher
DHR
$140B
$5.09M 0.36%
+41,496
New +$5.59M
IMVT icon
84
Immunovant
IMVT
$8.06B
$5.06M 0.36%
325,183
+52,644
+19% +$792K
DIOD icon
85
Diodes
DIOD
$3.93B
$5.05M 0.36%
+124,318
New +$5.96M
JNPR
86
DELISTED
Juniper Networks
JNPR
$5.01M 0.36%
+261,861
New +$5.88M
RGNX icon
87
Regenxbio
RGNX
$672M
$5.01M 0.36%
+154,621
New +$6.44M
AKBA icon
88
Akebia Therapeutics
AKBA
$346M
$4.75M 0.34%
626,710
-646,077
-51% -$5.03M
DXCM icon
89
DexCom
DXCM
$31.2B
$4.61M 0.33%
68,504
-137,340
-67% -$8.55M
SAGE
90
DELISTED
Sage Therapeutics
SAGE
$4.56M 0.33%
158,827
+138,535
+683% +$8.02M
PRTA icon
91
Prothena Corp
PRTA
$444M
$4.55M 0.32%
424,916
+100,911
+31% +$1.22M
CPAY icon
92
Corpay
CPAY
$25.8B
$4.48M 0.32%
+24,017
New +$6.63M
ORTX
93
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$4.45M 0.32%
59,125
+47,849
+424% +$5.51M
SNAP icon
94
Snap
SNAP
$8.97B
$4.4M 0.31%
369,898
-3,067,943
-89% -$47.1M
ON icon
95
ON Semiconductor
ON
$29.9B
$4.38M 0.31%
+351,649
New +$6.88M
KN icon
96
Knowles
KN
$3.38B
$4.36M 0.31%
325,680
-12,815
-4% -$223K
TDOC icon
97
Teladoc Health
TDOC
$1.26B
$4.24M 0.3%
+27,343
New +$3.18M
NFLX icon
98
Netflix
NFLX
$309B
$4.23M 0.3%
+112,580
New +$3.98M
ANET icon
99
Arista Networks
ANET
$248B
$4.12M 0.29%
+325,776
New +$4.23M
LH icon
100
Labcorp
LH
$25.4B
$4M 0.29%
+36,850
New +$5.31M

Similar funds

Woodline Partners's Q1 2020 Portfolio in Review

As of Q1 2020, Woodline Partners held 181 positions worth $1.4B, down 43% from $2.45B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Woodline Partners withdrew a net $737M in Q1 2020, closing 45 positions and reducing 42 holdings. Its most notable exit was Texas Instruments, an estimated $69.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 41% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Woodline Partners opened a new position in Pfizer worth $65.7M.

  • Woodline Partners's largest Q1 2020 buy was Pfizer: 2,120,811 shares worth $65.7M.
  • Woodline Partners added most to Immunomedics Inc in Q1 2020, an estimated $23M increase.
  • Woodline Partners's biggest Q1 2020 reduction was NVIDIA, cutting an estimated $61.4M.
  • Woodline Partners fully exited Texas Instruments in Q1 2020, selling an estimated $69.5M.
  • Woodline Partners's ten largest holdings make up 30% of its $1.4B portfolio in Q1 2020.
  • Woodline Partners opened 76 new positions and closed 45 in Q1 2020.
  • Woodline Partners's portfolio value fell 43% quarter-over-quarter to $1.4B.

Based on Woodline Partners's 13F filing for Q1 2020, filed 15 May 2020.